儿童大型耳科手术后阿片类药物处方趋势:12年分析
本研究回顾性分析了2010-2021年某儿童医院所有鼓室成形术、鼓室乳突切除术、乳突切除术、人工耳蜗植入术、耳廓成形术及耳道闭锁修复术病例,评估阿片类药物处方趋势。结果显示,无针对性方案下阿片类药物处方显著下降,2012年96.1%患者获处方降至2021年13.5%,疼痛相关返院率罕见(0.9%)且与阿片处方无关(p=0.37)。
要点
- 2012年至2021年,阿片类药物处方率从96.1%降至13.5%。
- 0-6岁患儿年度处方率从2012年最高96.3%降至2021年0.0%。
- 疼痛相关返院罕见(0.9%),且与阿片处方无关(p=0.37)。
核心结论
- 外科医生驱动的阿片类药物管理有所改善,且返院率无相应变化。
- 针对特定手术的质量改进干预可能对处方行为产生更广泛的脱靶效应。
研究设计与样本
- 本研究回顾了2010-2021年某儿童医院所有鼓室成形术、鼓室乳突切除术、乳突切除术、人工耳蜗植入术、耳廓成形术及耳道闭锁修复术病例。
- 采用回归分析识别阿片类药物处方随时间的变化趋势,并评估潜在协变量,同时审查返院情况作为平衡指标。
- 证据等级:IV级。
主要发现
- 即使没有针对性方案,阿片类药物处方仍显著下降;处方在2012-2013年达到峰值后,呈现显著负趋势,处方率降低、每张处方剂量数减少、患者体重标准化剂量规模减小且变异性降低(所有p < 0.001)。
- 2012年96.1%的患者获得阿片类药物处方,到2021年该比例降至13.5%。
- 0-6岁患儿年度阿片类药物处方率从2012年最高96.3%降至2021年0.0%。
- 每张处方年度平均供应剂量数在2013年至2021年间减少68%,总供应天数降至基于证据的3.1 ± 1.6天。
- 回归分析未检测到返院情况的变化;疼痛相关返院罕见(0.9%),且不随阿片类药物处方变化(p = 0.37)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Postoperative opioid prescriptions tend to exceed children's analgesic needs, but awareness of the opioid epidemic may have driven changes in prescribing behaviors. This study evaluated opioid prescribing patterns after major pediatric ear surgery. METHODS: This study reviewed all cases of tympanoplasty, tympanomastoidectomy, mastoidectomy, cochlear implantation, otoplasty, and aural atresia repair at a pediatric hospital during 2010-2021. Regressions were conducted to identify opioid prescribing trends over time. Potential covariates were assessed. Returns to the system were reviewed as a balancing measure. RESULTS: Even without a targeted protocol, opioid prescribing declined significantly. After prescribing peaked in 2012-2013, significant negative trends yielded lower rates of opioid prescriptions, fewer doses per prescription, smaller patient-weight-standardized dose sizes, and less variability (all p < 0.001). In 2012, 96.1% of patients received opioid prescriptions; the rate fell to 13.5% by 2021. For patients ages, 0-6, the annual rate of opioid prescriptions dropped from a maximum of 96.3% in 2012 to 0.0% in 2021. The annual average supply of doses per prescription decreased by 68% between 2013 and 2021, reducing the total days' supply to an evidence-based 3.1 ± 1.6 days. Regressions did not detect changes in returns to the system. Pain-related returns were rare (0.9%) and did not vary by opioid prescriptions (p = 0.37). Prescribing trends were closely correlated with a tonsillectomy-focused protocol that our institution implemented in 2019. CONCLUSION: Surgeon-driven opioid stewardship has improved with no resultant change in revisit rates. Procedure-specific quality improvement interventions may have broader off-target effects on prescribing behaviors. LEVEL OF EVIDENCE: IV Laryngoscope, 133:1987-1992, 2023.
引用
- Cordray H, Galvin J, Clark A, et al. Opioid Prescribing Trends After Major Pediatric Ear Surgery: A 12-Year Analysis. Laryngoscope. 2022. PMID: 36054608. doi:10.1002/lary.30379
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。